Subject:
All Disciplines Arts & Humanities Biology & Life Sciences Business & Economics Chemistry & Materials Science Computer Science & Mathematics Engineering Environmental & Earth Sciences Medicine & Pharmacology Physical Sciences Public Health & Healthcare Social Sciences
Sort:
Most Viewed Latest Alphabetical (A-Z) Alphabetical (Z-A)
Filter:
All Topic Review Biography Peer Reviewed Entry Video Entry
Topic Review
Iron in Health and Disease
Iron dysregulation is a common characteristic in many subtypes of acute lung injury (ALI). On the one hand, iron is needed to produce reactive oxygen species (ROS) as part of the immune response to an infection; on the other hand, iron can accelerate the occurrence of ferroptosis and extend host cell damage. Iron chelation represents a novel therapeutic strategy for alleviating lung injury and improving the survival of patients with ALI. 
  • 319
  • 10 Aug 2023
Topic Review
Efficacy and Safety of COVID-19 Vaccines
A few centuries ago, the first vaccine vial was formulated, and since then, they have resulted in an eminent reduction in infectious diseases associated morbidity and mortality. The discovery of the novel SARS-CoV-2 virus and the COVID-19 disease and its steady progression to a global pandemic with 603,711,760 confirmed cases and 6,484,136 reported deaths according to the World Health Organization (WHO) on 7 September 2022 was exceedingly catastrophic.
  • 317
  • 15 Sep 2023
Topic Review
Plant-Origin Components
Klebsiella pneumoniae (Kpn) is an opportunistic pathogen that causes intrahospital complications such as pneumonia, liver abscesses, soft tissue infections, urinary infections, bacteraemia, and, in some cases, death. Since this bacterium has a higher frequency than other Gram-negative pathogens, it has become an important pathogen to the health sector. The adaptative genome of Kpn likely facilitates increased survival of the pathogen in diverse situations.
  • 316
  • 20 Feb 2024
Topic Review
Invasive Mucormycosis in Patients with Hematological Malignancies
The incidence rate of invasive mucormycosis (IM) in patients with hematological malignancies (HMs) is increasing year by year, ranging from 0.07% to 4.29%, and the mortality rate is mostly higher than 50%. With the ongoing pandemic of COVID-19, COVID-19-associated mucormycosis (CAM) also became a global health threat.
  • 315
  • 30 May 2023
Topic Review
Hepatitis B Surface Antigen Isoforms
The hepatitis B surface antigen (HBsAg) is a multifunctional glycoprotein composed of large (LHB), middle (MHB), and small (SHB) subunits. HBsAg isoforms have numerous biological functions during HBV infection—from initial and specific viral attachment to the hepatocytes to initiating chronic infection with their immunomodulatory properties. Their immunogenic properties make them a major target for developing HBV vaccines, and they have been recognised as valuable targets for new therapeutic approaches. In addition, HBsAg isoform quantitation can become a useful non-invasive biomarker for assessing chronically infected patients.
  • 315
  • 11 Jan 2024
Topic Review
Novel Therapeutic Strategies against Multi-Drug Resistant Pseudomonas aeruginosa
Pseudomonas aeruginosa (P. aeruginosa) with multi-drug resistance (MDR) is a major cause of serious healthcare-associated infections, leading to high morbidity and mortality. This opportunistic pathogen is responsible for various infectious diseases, such as those seen in cystic fibrosis, ventilator-associated pneumonia, urinary tract infection, otitis externa, and burn and wound injuries. Due to its relatively large genome, P. aeruginosa has great diversity and can use various molecular mechanisms for antimicrobial resistance. 
  • 315
  • 23 Feb 2024
Topic Review
Nitric Oxide as a Therapeutic Agent against SARS-CoV-2
Nitric oxide (NO) is a key player in both the cardiopulmonary and immune systems, which has already been reported as a worthy candidate for use in the treatment of human coronavirus infections, including COVID-19, because of its antivirus activity and its beneficial effects in the treatment of clinical complications in patients. In fact, inhaled nitric oxide (iNO), as a potent vasodilator, was approved to improve oxygenation in term and near-term neonates, and has been used in clinical settings. Along with its putative antiviral affect, iNO can reduce inflammatory cell-mediated lung injury by inhibiting neutrophil activation, lowering pulmonary vascular resistance, and decreasing edema in the alveolar spaces, thus collectively enhancing ventilation/perfusion matching.
  • 312
  • 20 Dec 2023
Topic Review
Animal-Associated Methicillin-Resistant Staphylococcus aureus
Methicillin-resistant Staphylococcus aureus (MRSA) remains an important etiological factor of human and animal infectious diseases, causing significant economic losses not only in human healthcare but also in the large-scale farming sector. The constantly changing epidemiology of MRSA observed globally affects animal welfare and raises concerns for public health. High MRSA colonization rates in livestock raise questions about the meaning of reservoirs and possible transmission pathways, while the prevalence of MRSA colonization and infection rates among companion animals vary and might affect human health in multiple ways.
  • 311
  • 05 Jul 2023
Topic Review
Protease Inhibitors as Antivirals
Viral proteases play a key role in viral replication for all positive single-stranded RNA viruses and some DNA viruses, such as herpesviruses. To treat infections caused by these viruses, proteases are considered excellent drug targets. Protease inhibitors are now routinely used in antiviral therapy for human immunodeficiency virus (HIV) and hepatitis C virus (HCV) infections. Since SARS-CoV-2 Mpro plays a key role in viral replication by cleaving viral polyproteins, inhibition of its catalytic activity represents an attractive therapeutic approach for the treatment of COVID-19.
  • 310
  • 08 Feb 2024
Topic Review
MAIT Cell-Directed Therapy for Tuberculosis Infection
Mucosal-associated invariant T (MAIT) cells are a distinct population of non-conventional T cells that have been preserved through evolution and possess properties of both innate and adaptive immune cells. They are activated through the recognition of antigens presented by non-polymorphic MR1 proteins or, alternately, can be stimulated by specific cytokines.
  • 308
  • 30 Nov 2023
Topic Review
Alterations of Vaginal Microbiota and Chlamydiatrachomatis
Alterations of Vaginal Microbiota and Chlamydia trachomatis as crucial co-causative factors in cervical cancer genesis procured by HPV. Nowadays, it is widely accepted that some types of infections caused by certain viruses, bacteria, and parasites may be the cause of high-risk factors for several types of cancer in humans. These pathogens evolved strategies to hamper the host's integrity of defense such as the prevention of the apoptosis mechanism pathway of the damaged cells reducing the ability to repair the damage(s) and eventually resulting in cellular transformation, cancer progression, and reduced response to therapy.
  • 306
  • 27 Mar 2023
Topic Review
Sinonasal Orbital Apex Syndrome
Rhinosinusitis (RS) is an inflammatory disease of the nose and paranasal sinuses with a clinical picture of anterior or posterior nasal discharge, congestion, olfactory dysfunction, and facial pain or pressure. It must be confirmed with endoscopic or radiological signs of inflammation. By its duration, it is classified into acute (i.e., duration <4 weeks), subacute (4–12 weeks), and chronic RS (>12 weeks). Moreover, RS can be named according to the inflamed paranasal sinus, e.g., sphenoiditis in sphenoid sinus inflammation. RS significantly affects the patient’s quality of life due to the significant impact on personal development, sleep hygiene, mental health, physical condition, self-perception, and family relationships.
  • 301
  • 02 Aug 2023
Topic Review
Principles of Rational COVID-19 Therapy in Pediatrics
A structural analysis of the range of drugs and treatment strategies in the context of etiotropic, pathogenetic, and symptomatic therapy has shown that in the global context and in real clinical practice, the etiotropic-pathogenetic approach based on information about the effectiveness of individual medical technologies prevails today. It has been established that eight international nonproprietary/grouping names are present in international practice as means of etiotropic therapy for pediatric patients with COVID-19, and 18 positions are used for pathogenetic therapy. In terms of frequency of occurrence, the leading positions are occupied by remdesivir and the combination of nirmatrelvir with ritonavir, as well as dexamethasone and tocilizumab.
  • 296
  • 14 Aug 2023
Topic Review
Precision Vaccinology Approaches for Adjuvanted Vaccines
Infection persists as one of the leading global causes of morbidity and mortality, with particular burden at the extremes of age and in populations who are immunocompromised or suffer chronic co-morbid diseases. By focusing discovery and innovation efforts to better understand the phenotypic and mechanistic differences in the immune systems of diverse vulnerable populations, emerging research in precision vaccine discovery and development has explored how to optimize immunizations across the lifespan. 
  • 296
  • 07 Oct 2023
Topic Review
Interrelationship between COVID-19 and Coagulopathy
Since the first description of COVID-19 infection, among clinical manifestations of the disease, including fever, dyspnea, cough, and fatigue, it was observed a high incidence of thromboembolic events potentially evolving towards acute respiratory distress syndrome (ARDS) and COVID-19-associated-coagulopathy (CAC). The hypercoagulation state is based on an interaction between thrombosis and inflammation. The so-called CAC represents a key aspect in the genesis of organ damage from SARS-CoV-2. The prothrombotic status of COVID-19 can be explained by the increase in coagulation levels of D-dimer, lymphocytes, fibrinogen, interleukin 6 (IL-6), and prothrombin time. Several mechanisms have been hypothesized to explain this hypercoagulable process such as inflammatory cytokine storm, platelet activation, endothelial dysfunction, and stasis for a long time. 
  • 293
  • 24 May 2023
Topic Review
Psittacosis
The bacterial agent Chlamydia psittaci, and the resulting disease of psittacosis, is a little-known and underappreciated infectious disease by healthcare practitioners and in public health in general. C. psittaci infections can cause significant psittacosis outbreaks with pandemic potential, with person-to-person transmission being documented in the last decade.
  • 291
  • 16 Oct 2023
Topic Review
HIV and Drug-Resistant Subtypes
Acquired Immunodeficiency Syndrome (AIDS) is a human viral infectious disease caused by the positive-sense single-stranded (ss) RNA Human Immunodeficiency Virus (HIV) (Retroviridae family, Ortervirales order). HIV-1 can be distinguished into various worldwide spread groups and subtypes. HIV-2 also causes human immunodeficiency, which develops slowly and tends to be less aggressive. HIV-2 only partially homologates to HIV-1 despite the similar derivation. Antiretroviral therapy (ART) is the treatment approved to control HIV infection, based on multiple antiretroviral drugs that belong to different classes: (i) NNRTIs, (ii) NRTIs, (iii) PIs, (iv) INSTIs, and (v) entry inhibitors. These drugs, acting on different stages of the HIV life cycle, decrease the patient’s total burden of HIV, maintain the function of the immune system, and prevent opportunistic infections.
  • 290
  • 15 May 2023
Topic Review
Mycobacterium avium ssp. paratuberculosis and Crohn’s Disease
Mycobacterium avium ssp. paratuberculosis (MAP) is the cause of Johne’s disease (JD), which is a chronic infectious gastrointestinal disease of ruminants and is often fatal. In humans, MAP has been associated with Crohn’s disease (CD) for over a century, without conclusive evidence of pathogenicity. Numerous researchers have contributed to the subject, but there is still a need for evidence of the causation of CD by MAP.
  • 290
  • 07 Mar 2024
Topic Review
Mechanisms of SARS-CoV-2-Induced Neurological Damage
COVID-19 patients can exhibit a wide range of clinical manifestations affecting various organs and systems. Neurological symptoms have been reported in COVID-19 patients, both during the acute phase of the illness and in cases of long-term COVID. Moderate symptoms include ageusia, anosmia, altered mental status, and cognitive impairment, and in more severe cases can manifest as ischemic cerebrovascular disease and encephalitis.
  • 290
  • 03 Nov 2023
Topic Review
ApiAP2 Transcription Factors as Malaria Control Drug Targets
The complex life cycle of the malaria parasite Plasmodium requires the parasite to adequately adapt to different conditions. For this reason, Plasmodium strictly controls its gene expression, and given its evolutionary distance from the human host, the involved factors may figure as attractive potential drug targets. In recent years, several unique transcription factors and chromatin modifiers have been identified and partially characterized in Plasmodium falciparum and in the murine species P. yoelii and P. berghei. Due to their structural differences compared with human factors, they may be attractive drug targets. 
  • 289
  • 24 Nov 2023
  • Page
  • of
  • 32
Featured Entry Collections
>>

Featured Books

>>
Encyclopedia of Social Sciences
Encyclopedia of COVID-19
Encyclopedia of Fungi
Encyclopedia of Digital Society, Industry 5.0 and Smart City
ScholarVision Creations
Feedback